OKYO Pharma Ltd EMMLF:OTCQB

RT Quote | Exchange | USD
Last | 05/26/22 EDT
0.0484UNCH (UNCH)
52 week range
0.05 - 0.11
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.0484
  • 52 Week High0.11
  • 52 Week High Date04/18/22
  • 52 Week Low0.05
  • 52 Week Low Date05/26/22

Key Stats

  • Market Cap23.99M
  • Shares Out672.57M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.0484
  • 52 Week High0.11
  • 52 Week High Date04/18/22
  • 52 Week Low0.05
  • 52 Week Low Date05/26/22
  • Market Cap23.99M
  • Shares Out672.57M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.00
  • P/E (TTM)-11.86
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On OKYO Pharma Ltd

There is no recent news for this security.

Content From Our Affiliates

Profile

MORE
OKYO Pharma Limited is a United Kingdom-based preclinical biopharmaceutical company. The Company’s principal activity is to develop drugs for inflammatory dry eye diseases and chronic pain by targeting G protein-coupled receptors (GPCRs). The GPCRs is the family of membrane proteins involved in many biological processes. GPCRs is used for the treatment of various conditions, including cardiovascular disease, cancer, and diabetes. Its product pipeline includes OK-101 for Dry...
Address
55 Park Lane
London
W1K 1NA
United Kingdom